211 related articles for article (PubMed ID: 31969533)
1. Eicosapentaenoic-to-Arachidonic Acid Ratio Predicts Mortality and Recurrent Vascular Events in Ischemic Stroke Patients.
Shojima Y; Ueno Y; Tanaka R; Yamashiro K; Miyamoto N; Hira K; Kurita N; Nakajima S; Urabe T; Hattori N
J Atheroscler Thromb; 2020 Sep; 27(9):969-977. PubMed ID: 31969533
[TBL] [Abstract][Full Text] [Related]
2. Association between ratio of serum eicosapentaenoic acid to arachidonic acid and risk of cardiovascular disease: the Hisayama Study.
Ninomiya T; Nagata M; Hata J; Hirakawa Y; Ozawa M; Yoshida D; Ohara T; Kishimoto H; Mukai N; Fukuhara M; Kitazono T; Kiyohara Y
Atherosclerosis; 2013 Dec; 231(2):261-7. PubMed ID: 24267237
[TBL] [Abstract][Full Text] [Related]
3. The eicosapentaenoic acid:arachidonic acid ratio and its clinical utility in cardiovascular disease.
Nelson JR; Raskin S
Postgrad Med; 2019 May; 131(4):268-277. PubMed ID: 31063407
[TBL] [Abstract][Full Text] [Related]
4. Associations With Eicosapentaenoic Acid to Arachidonic Acid Ratio and Mortality in Hospitalized Heart Failure Patients.
Watanabe S; Yoshihisa A; Kanno Y; Takiguchi M; Yokokawa T; Sato A; Miura S; Shimizu T; Abe S; Sato T; Suzuki S; Oikawa M; Sakamoto N; Yamaki T; Sugimoto K; Kunii H; Nakazato K; Suzuki H; Saitoh SI; Takeishi Y
J Card Fail; 2016 Dec; 22(12):962-969. PubMed ID: 27138463
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of the serum eicosapentaenoic acid to arachidonic acid ratio in relation to clinical outcomes after endovascular therapy in patients with peripheral artery disease caused by femoropopliteal artery lesions.
Hishikari K; Kimura S; Yamakami Y; Kojima K; Sagawa Y; Otani H; Sugiyama T; Kuwahara T; Hikita H; Takahashi A; Isobe M
Atherosclerosis; 2015 Apr; 239(2):583-8. PubMed ID: 25733330
[TBL] [Abstract][Full Text] [Related]
6. Polyunsaturated Fatty Acid Impact on Clinical Outcomes in Acute Coronary Syndrome Patients With Dyslipidemia: Subanalysis of HIJ-PROPER.
Arashi H; Yamaguchi J; Kawada-Watanabe E; Koyanagi R; Sekiguchi H; Mori F; Haruta S; Ishii Y; Murasaki S; Suzuki K; Yamauchi T; Ogawa H; Hagiwara N
J Am Heart Assoc; 2019 Aug; 8(16):e012953. PubMed ID: 31390907
[TBL] [Abstract][Full Text] [Related]
7. Age Stratification and Impact of Eicosapentaenoic Acid and Docosahexaenoic Acid to Arachidonic Acid Ratios in Ischemic Stroke Patients.
Ueno Y; Tanaka R; Yamashiro K; Miyamoto N; Hira K; Kurita N; Sakurai M; Urabe T; Shimada K; Miyazaki T; Daida H; Hattori N
J Atheroscler Thromb; 2018 Jul; 25(7):593-605. PubMed ID: 29199200
[TBL] [Abstract][Full Text] [Related]
8. The Influence of Eicosapentaenoic Acid to Arachidonic Acid Ratio on Long-term Cardiovascular Events Following Percutaneous Coronary Intervention.
Niwa K; Tanaka A; Funakubo H; Otsuka S; Yoshioka N; Kudo N; Tobe A; Sakakibara K; Miki Y; Kataoka T; Furusawa K; Ishii H; Murohara T
Intern Med; 2021 Dec; 60(24):3865-3871. PubMed ID: 34148960
[TBL] [Abstract][Full Text] [Related]
9. Clinical implications of eicosapentaenoic acid/arachidonic acid ratio (EPA/AA) in adult patients with congenital heart disease.
Kanoh M; Inai K; Shinohara T; Tomimatsu H; Nakanishi T
Heart Vessels; 2017 Dec; 32(12):1513-1522. PubMed ID: 28681101
[TBL] [Abstract][Full Text] [Related]
10. Eicosapentaenoic acid to arachidonic acid (EPA/AA) ratio as an associated factor of high risk plaque on coronary computed tomography in patients without coronary artery disease.
Nagahara Y; Motoyama S; Sarai M; Ito H; Kawai H; Takakuwa Y; Miyagi M; Shibata D; Takahashi H; Naruse H; Ishii J; Ozaki Y
Atherosclerosis; 2016 Jul; 250():30-7. PubMed ID: 27175609
[TBL] [Abstract][Full Text] [Related]
11. Comparison of eicosapentaenoic acid concentrations in plasma between patients with ischemic stroke and control subjects.
Ikeya Y; Fukuyama N; Kitajima W; Ogushi Y; Mori H
Nutrition; 2013 Jan; 29(1):127-31. PubMed ID: 23010418
[TBL] [Abstract][Full Text] [Related]
12. Study protocol and baseline characteristics of Randomized trial for Evaluation in Secondary Prevention Efficacy of Combination Therapy-Statin and Eicosapentaenoic Acid: RESPECT-EPA, the combination of a randomized control trial and an observational biomarker study.
Nishizaki Y; Miyauchi K; Iwata H; Inoue T; Hirayama A; Kimura K; Ozaki Y; Murohara T; Ueshima K; Kuwabara Y; Tanaka-Mizuno S; Yanagisawa N; Sato T; Daida H
Am Heart J; 2023 Mar; 257():1-8. PubMed ID: 36372250
[TBL] [Abstract][Full Text] [Related]
13. The ratio of serum n-3 to n-6 polyunsaturated fatty acids is associated with diabetes mellitus in patients with prior myocardial infarction: a multicenter cross-sectional study.
Takahashi M; Ando J; Shimada K; Nishizaki Y; Tani S; Ogawa T; Yamamoto M; Nagao K; Hirayama A; Yoshimura M; Daida H; Nagai R; Komuro I
BMC Cardiovasc Disord; 2017 Jan; 17(1):41. PubMed ID: 28125968
[TBL] [Abstract][Full Text] [Related]
14. Correlation between the serum eicosapentanoic acid-to-arachidonic acid ratio and the severity of cerebral white matter hyperintensities in older adults with memory disorder.
Nagai K; Koshiba H; Shibata S; Matsui T; Kozaki K
Geriatr Gerontol Int; 2015 Dec; 15 Suppl 1():48-52. PubMed ID: 26671157
[TBL] [Abstract][Full Text] [Related]
15. Eicosapentaenoic Acid and Prevalence of Cardiovascular Disease in Hemodialysis Patients.
Honda T; Kishi S; Furukawa E; Ambe H; Kurata Y; Ichikawa M; Aoe M; Ohara K; Furuse S; Saito K; Nishio K; Masaki K; Kano T; Mise N
Ther Apher Dial; 2018 Oct; 22(5):514-518. PubMed ID: 29987872
[TBL] [Abstract][Full Text] [Related]
16. Eicosapantaenoic acid treatment based on the EPA/AA ratio in patients with coronary artery disease: follow-up data from the Tochigi Ryomo EPA/AA Trial in Coronary Artery Disease (TREAT-CAD) study.
Abe S; Sugimura H; Watanabe S; Murakami Y; Ebisawa K; Ioka T; Takahashi T; Ando T; Kono K; Inoue T
Hypertens Res; 2018 Nov; 41(11):939-946. PubMed ID: 30237446
[TBL] [Abstract][Full Text] [Related]
17. Eicosapentaenoic Acid and the Outcomes in Older Patients Undergoing Atrial Fibrillation Ablation.
Sudo Y; Morimoto T; Tsushima R; Oka A; Sogo M; Ozaki M; Takahashi M; Okawa K
J Am Heart Assoc; 2024 Jun; 13(12):e033969. PubMed ID: 38879457
[TBL] [Abstract][Full Text] [Related]
18. Altered Serum n-6 Polyunsaturated Fatty Acid Profile and Risks of Mortality and Cardiovascular Events in a Cohort of Hemodialysis Patients.
Kuwamura Y; Shoji T; Okute Y; Yamazaki Y; Motoyama K; Morioka T; Mori K; Fukumoto S; Tsujimoto Y; Shioi A; Emoto M; Inaba M
J Ren Nutr; 2018 Jan; 28(1):54-63. PubMed ID: 29089279
[TBL] [Abstract][Full Text] [Related]
19. Relationship Between Serum Eicosapentaenoic Acid to Arachidonic Acid Ratio and Atherosclerotic Risk Factors in Patients With Peripheral Artery Disease.
Nishibe T; Dardik A; Nishibe M; Kano M; Matsumoto R; Nakano Y; Maekawa K; Irikata Y; Ogino H; Ono S; Koizumi J
Vasc Endovascular Surg; 2021 Feb; 55(2):112-116. PubMed ID: 33073735
[TBL] [Abstract][Full Text] [Related]
20. Variations in the eicosapentaenoic acid-arachidonic acid ratio associated with age in acute myocardial infarction patients undergoing primary percutaneous coronary intervention.
Nakabayashi K; Jujo K; Furuki Y; Ishida I; Ando H; Shimizu M; Hagiwara N; Saito K
Heart Vessels; 2019 May; 34(5):755-762. PubMed ID: 30430295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
